Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
Needle-free jet injector (NFJI) devices offer an alternative to traditional needle–syringe injection for administration of medications, vaccines, and other fluids.
Biostimulators and energy-based devices are increasingly used in combination to address visible signs of aging.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
The recent Facial and Rhinoplasty Symposium was a tremendous success – and a great example of how The Society is evolving to meet the needs of our members and the demands of a fast-changing industry.
Dr. Tracy Pfeifer highlights key developments for The Aesthetic Society, including the new impact factor for Aesthetic Surgery Journal, evolving needs across generations of surgeons, plans for The Aesthetic MEET 2026, upcoming participation at ISAPS in Singapore, and an important cybersecurity alert for members.